Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B M Buckley

Showing results (61-70 of 71) with videos related to

Pageof 8
Sort By:
Geophysical Research Letters|June 29, 2018
European and Mediterranean hydroclimate responses to tropical volcanic forcing over the last millenniumM P Rao, B I Cook, E R Cook, et al.
European Journal of Clinical Pharmacology|December 22, 2015
Non-response to (statin) therapy: the importance of distinguishing non-responders from non-adherers in pharmacogenetic studiesS Trompet, I Postmus, P E Slagboom, et al.
Experimental Gerontology|May 28, 2008
Lymphotoxin-alpha C804A polymorphism is a risk factor for stroke. The PROSPER studyS Trompet, A J M de Craen, P Slagboom, et al.
Brain : a Journal of Neurology|February 29, 2008
Genetic variation in the interleukin-1 beta-converting enzyme associates with cognitive function. The PROSPER studyS Trompet, A J M de Craen, P Slagboom, et al.
Diabetologia|November 26, 2008
Are elevated circulating intercellular adhesion molecule 1 levels more strongly predictive of diabetes than vascular risk? Outcome of a prospective study in the elderlyN Sattar, H M Murray, P Welsh, et al.
The American Journal of Cardiology|November 24, 1999
The design of a prospective study of Pravastatin in the Elderly at Risk (PROSPER). PROSPER Study Group. PROspective Study of Pravastatin in the Elderly at RiskJ Shepherd, G J Blauw, M B Murphy, et al.
Annals of the New York Academy of Sciences|April 27, 2007
Genetic variation in the interleukin-10 gene promoter and risk of coronary and cerebrovascular events: the PROSPER studyS Trompet, D Pons, A J M DE Craen, et al.
The Pharmacogenomics Journal|March 6, 2013
Drug-gene interactions and the search for missing heritability: a cross-sectional pharmacogenomics study of the QT intervalC L Avery, C M Sitlani, D E Arking, et al.
The Pharmacogenomics Journal|July 19, 2017
Pharmacogenomics study of thiazide diuretics and QT interval in multi-ethnic populations: the cohorts for heart and aging research in genomic epidemiologyA A Seyerle, C M Sitlani, R Noordam, et al.
Molecular Psychiatry|February 4, 2015
Genetic contributions to variation in general cognitive function: a meta-analysis of genome-wide association studies in the CHARGE consortium (N=53949)G Davies, N Armstrong, J C Bis, et al.
Pageof 8

Showing results (61-70 of 71) with videos related to

Sort By:
Pageof 8
Geophysical Research Letters|June 29, 2018
European and Mediterranean hydroclimate responses to tropical volcanic forcing over the last millenniumM P Rao, B I Cook, E R Cook, et al.
European Journal of Clinical Pharmacology|December 22, 2015
Non-response to (statin) therapy: the importance of distinguishing non-responders from non-adherers in pharmacogenetic studiesS Trompet, I Postmus, P E Slagboom, et al.
Experimental Gerontology|May 28, 2008
Lymphotoxin-alpha C804A polymorphism is a risk factor for stroke. The PROSPER studyS Trompet, A J M de Craen, P Slagboom, et al.
Brain : a Journal of Neurology|February 29, 2008
Genetic variation in the interleukin-1 beta-converting enzyme associates with cognitive function. The PROSPER studyS Trompet, A J M de Craen, P Slagboom, et al.
Diabetologia|November 26, 2008
Are elevated circulating intercellular adhesion molecule 1 levels more strongly predictive of diabetes than vascular risk? Outcome of a prospective study in the elderlyN Sattar, H M Murray, P Welsh, et al.
The American Journal of Cardiology|November 24, 1999
The design of a prospective study of Pravastatin in the Elderly at Risk (PROSPER). PROSPER Study Group. PROspective Study of Pravastatin in the Elderly at RiskJ Shepherd, G J Blauw, M B Murphy, et al.
Annals of the New York Academy of Sciences|April 27, 2007
Genetic variation in the interleukin-10 gene promoter and risk of coronary and cerebrovascular events: the PROSPER studyS Trompet, D Pons, A J M DE Craen, et al.
The Pharmacogenomics Journal|March 6, 2013
Drug-gene interactions and the search for missing heritability: a cross-sectional pharmacogenomics study of the QT intervalC L Avery, C M Sitlani, D E Arking, et al.
The Pharmacogenomics Journal|July 19, 2017
Pharmacogenomics study of thiazide diuretics and QT interval in multi-ethnic populations: the cohorts for heart and aging research in genomic epidemiologyA A Seyerle, C M Sitlani, R Noordam, et al.
Molecular Psychiatry|February 4, 2015
Genetic contributions to variation in general cognitive function: a meta-analysis of genome-wide association studies in the CHARGE consortium (N=53949)G Davies, N Armstrong, J C Bis, et al.
Pageof 8